Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2018

May 14, 2018

SELL
$17.46 - $32.59 $4.54 Million - $8.47 Million
-260,000 Reduced 56.52%
200,000 $0
Q3 2017

Nov 14, 2017

BUY
$16.81 - $21.61 $7.73 Million - $9.94 Million
460,000
460,000 $9.21 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.